Literature DB >> 20634114

Autonomic disturbances in narcolepsy.

Giuseppe Plazzi1, Keivan Kaveh Moghadam, Leonardo Serra Maggi, Vincenzo Donadio, Roberto Vetrugno, Rocco Liguori, Giovanna Zoccoli, Francesca Poli, Fabio Pizza, Uberto Pagotto, Raffaele Ferri.   

Abstract

Narcolepsy is a clinical condition characterized mainly by excessive sleepiness and cataplexy. Hypnagogic hallucinations and sleep paralysis complete the narcoleptic tetrad; disrupted night sleep, automatic behaviors and weight gain are also usual complaints. Different studies focus on autonomic changes or dysfunctions among narcoleptic patients, such as pupillary abnormalities, fainting spells, erectile dysfunction, night sweats, gastric problems, low body temperature, systemic hypotension, dry mouth, heart palpitations, headache and extremities dysthermia. Even if many studies lack sufficient standardization or their results have not been replicated, a non-secondary involvement of the autonomic nervous system in narcolepsy is strongly suggested, mainly by metabolic and cardiovascular findings. Furthermore, the recent discovery of a high risk for overweight and for metabolic syndrome in narcoleptic patients represents an important warning for clinicians in order to monitor and follow them up for their autonomic functions. We review here studies on autonomic functions and clinical disturbances in narcoleptic patients, trying to shed light on the possible contribute of alterations of the hypocretin system in autonomic pathophysiology.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634114     DOI: 10.1016/j.smrv.2010.05.002

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  24 in total

Review 1.  Central nervous system regulation of brown adipose tissue.

Authors:  Shaun F Morrison; Christopher J Madden
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 2.  Central neural regulation of brown adipose tissue thermogenesis and energy expenditure.

Authors:  Shaun F Morrison; Christopher J Madden; Domenico Tupone
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

Review 3.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 4.  REM sleep: a biological and psychological paradox.

Authors:  Jerome M Siegel
Journal:  Sleep Med Rev       Date:  2011-04-08       Impact factor: 11.609

Review 5.  Neurological Sleep Disorders and Blood Pressure: Current Evidence.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

6.  Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features.

Authors:  Virginia Ponziani; Monia Gennari; Fabio Pizza; Antonio Balsamo; Filippo Bernardi; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

Review 7.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

8.  Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons.

Authors:  Sultan Cingoz; Sinem Agilkaya; Ibrahim Oztura; Secil Eroglu; Derya Karadeniz; Ahmet Evlice; Oguz Altungoz; Hikmet Yilmaz; Baris Baklan
Journal:  Genet Test Mol Biomarkers       Date:  2014-02-26

9.  Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.

Authors:  Sarah Wurts Black; Stephen R Morairty; Simon P Fisher; Tsui-Ming Chen; Deepti R Warrier; Thomas S Kilduff
Journal:  Sleep       Date:  2013-03-01       Impact factor: 5.849

Review 10.  The hypocretin system and psychiatric disorders.

Authors:  Fabio Pizza; Michele Magnani; Camilla Indrio; Giuseppe Plazzi
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.